Evidence map›Paper›PMID 33233689›Full record

ArticleCancers2020

DNAJA3/Tid1 Is Required for Mitochondrial DNA Maintenance and Regulates Migration and Invasion of Human Gastric Cancer Cells.

Sheng-Fan Wang, Kuo-Hung Huang, Wei-Chuan Tseng, Jeng-Fan Lo, Anna Fen-Yau Li, Wen-Liang Fang, Chian-Feng Chen, Tien-Shun Yeh, Yuh-Lih Chang, Yueh-Ching Chou and 2 more

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. DNAJA: emerging targets for anti-tumor therapy.Future oncology (London, England) · 2025
    Review
  8. Article
  9. Energy metabolism: a new target for gastric cancer treatment.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2024
    Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Sheng-Fan WangDepartment of Pharmacy, Taipei Veterans General Hospital, Taipei 112, Taiwan.
Kuo-Hung HuangSchool of Medicine, National Yang-Ming University, Taipei 112, Taiwan.ORCID 0000-0002-5388-8117
Wei-Chuan TsengDepartment and Institute of Pharmacology, School of Medicine, National Yang-Ming University, Taipei 112, Taiwan.
Jeng-Fan LoDepartment and Institute of Pharmacology, School of Medicine, National Yang-Ming University, Taipei 112, Taiwan.ORCID 0000-0001-7188-9140
Anna Fen-Yau LiSchool of Medicine, National Yang-Ming University, Taipei 112, Taiwan.
Wen-Liang FangSchool of Medicine, National Yang-Ming University, Taipei 112, Taiwan.
Chian-Feng ChenCancer Progression Research Center, National Yang-Ming University, Taipei 112, Taiwan.ORCID 0000-0002-4906-7949
Tien-Shun YehInstitute of Anatomy and Cell Biology, School of Medicine, National Yang-Ming University, Taipei 112, Taiwan.
Yuh-Lih ChangDepartment of Pharmacy, Taipei Veterans General Hospital, Taipei 112, Taiwan.
Yueh-Ching ChouDepartment of Pharmacy, Taipei Veterans General Hospital, Taipei 112, Taiwan.
Hung-Hsu HungSchool of Medicine, Faculty of Medicine, National Yang-Ming University, Taipei 112, Taiwan.
Hsin-Chen LeeDepartment and Institute of Pharmacology, School of Medicine, National Yang-Ming University, Taipei 112, Taiwan.ORCID 0000-0001-7455-9593
National Yang Ming Chiao Tung University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGastric cancer is a common health issue. Deregulated cellular energetics is regarded as a cancer hallmark and mitochondrial dysfunction might contribute to cancer progression. Tid1, a mitochondrial co-chaperone, may play a role as a tumor suppressor in various cancers, but the role of Tid1 in gastric cancers remains under investigated.

methodsThe clinical TCGA online database and immunohistochemical staining for Tid1 expression in tumor samples of gastric cancer patients were analyzed. Tid1 knockdown by siRNA was applied to investigate the role of Tid1 in gastric cancer cells.

resultsLow Tid1 protein-expressing gastric cancer patients had a poorer prognosis and higher lymph node invasion than high Tid1-expressing patients. Knockdown of Tid1 did not increase cell proliferation, colony/tumor sphere formation, or chemotherapy resistance in gastric cancer cells. However, Tid1 knockdown increased cell migration and invasion. Moreover, Tid1 knockdown reduced the mtDNA copy number of gastric cancer cells. In addition, the Tid1-galectin-7-MMP-9 axis might be associated with Tid1 knockdown-induced cell migration and invasion of gastric cancer cells.

conclusionsTid1 is required for mtDNA maintenance and regulates migration and invasion of gastric cancer cells. Tid1 deletion may be a poor prognostic factor in gastric cancers and could be further investigated for development of gastric cancer treatments.

Indexed as

cancer progressiongalectin-7gastric cancermitochondriaMMP-9Tid1

Identifiers

PMID33233689
PMCPMC7699785
OpenAlexW3102064967

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.